Animal-assisted therapy involves the use of highly trained animals, such as dogs and cats, in conjunction with conventional treatments to address the physical and emotional needs of patients. This article presents a literature review of the health benefits and challenges associated with the use of animal-assisted therapy in the care of older patients in hospitals and long-term care facilities. Eleven original research articles were included and three themes were identified: physiological outcomes, psychological outcomes, and challenges associated with using animal-assisted therapy in patient care. The literature review aims to enhance nurses' knowledge of the health benefits of animal-assisted therapy as an adjunct to traditional treatments. It found that animal-assisted therapy can improve sleep, reduce depression and enhance mood in older patients. Challenges were identified in relation to ensuring infection prevention and control and in sustaining the implementation and benefits of interventions. Further research is necessary to explore the sustainability and long-term benefits of animal-assisted therapy in healthcare settings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7748/ns.2020.e11625 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Healthcare professionals' attitudes to animal assisted activity with dogs in paediatric care.
Complement Ther Clin Pract
January 2025
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Background: Hospitalization for children often involves stress induced by fear and pain. Complementary therapies, such as Animal Assisted Activities (AAA) with dogs, can alleviate the hospital experience.
Purpose: The first aim of this study was to initiate the development of an instrument that measures healthcare professionals' attitudes toward complementary therapy, specifically dogs in AAA.
Antimicrobial activity of Lactobacillus casei on Staphylococcus pseudintermedius isolates.
Vet Dermatol
January 2025
Department of Veterinary Clinic, School of Veterinary Medicine and Animal Science, São Paulo State University (UNESP), Botucatu, Brazil.
Background: Antimicrobial resistance is increasing each year. For example, in 2019 it was directly responsible for an estimated >1 million deaths. Additionally, the development of new drugs is much slower, generating enormous concerns about responses to infection in the future health scenario.
View Article and Find Full Text PDFRepression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair.
Cell Commun Signal
January 2025
Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.
Background: Ovarian cancer (OC), particularly high-grade serous ovarian carcinoma (HGSOC), is the leading cause of mortality from gynecological malignancies worldwide. Despite the initial effectiveness of treatment, acquired resistance to poly(ADP-ribose) polymerase inhibitors (PARPis) represents a major challenge for the clinical management of HGSOC, highlighting the necessity for the development of novel therapeutic strategies. This study investigated the role of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), a pivotal regulator of glycolysis, in PARPi resistance and explored its potential as a therapeutic target to overcome PARPi resistance.
View Article and Find Full Text PDFBehavioral and Physiological Responses of Therapy Dogs to Animal-Assisted Treatment in an Inpatient Stroke Rehabilitation Program.
Animals (Basel)
January 2025
Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Therapy dogs have been increasingly incorporated into a variety of medical treatment programs to improve patients' treatment outcomes and wellbeing. However, research investigating the stress level of therapy dogs in this setting is limited. This is the first randomized-controlled and prospective study that investigated the wellbeing of therapy dogs in an inpatient stroke rehabilitation program.
View Article and Find Full Text PDFMachine learning and confirmatory factor analysis show that buprenorphine alters motor and anxiety-like behaviors in male, female, and obese C57BL/6J mice.
J Neurophysiol
February 2025
Neuroscience Program in Psychology, The University of Tennessee, Knoxville, Tennessee, United States.
Buprenorphine is an opioid approved for medication-assisted treatment of opioid use disorder. Used off-label, buprenorphine has been reported to contribute to the clinical management of anxiety. Although human anxiety is a highly prevalent disorder, anxiety is a latent construct that cannot be directly measured.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!